Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001641172-25-023985
Filing Date
2025-08-14
Accepted
2025-08-14 16:05:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9823
  Complete submission text file 0001641172-25-023985.txt   11860
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-45947 | Film No.: 251218743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Filed by) CIK: 0001278951 (see all company filings)

EIN.: 134118850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A